Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Norvista Capital Corporation Announces Normal Course Issuer Bid
-
Waterton Sends Letter to Hudbay Shareholders Highlighting Entrenchment and Track Record of Poor Strategic Decision-Making of Hudbay's Board
-
CORRECTING and REPLACING Waterton Sends Letter to Hudbay Shareholders Highlighting Entrenchment and Track Record of Poor Strategic Decision-Making of Hudbay's Board
-
Difference Capital to Combine With Mogo Finance Technology
-
New Gold (NGD:CN) (NGD) PT Raised to $1.20 at Canaccord Genuity
-
Fortuna Silver Mines (FVI:CN) (FSM) PT Raised to Cdn$6.50 at Canaccord Genuity
-
Teck Resources Ltd (TECK-B:CN) (TECK) PT Lowered to Cdn$39 at Canaccord Genuity
-
Ivanhoe Mines Ltd. (IVN:CN) (IVPAF) PT Raised to Cdn$7.50 at Canaccord Genuity
-
Trevali Mining Corp. (TV:cN) (TREVF) PT Lowered to Cdn$0.65 at Canaccord Genuity
-
HudBay Minerals (HBM:CN) (HBM) PT Raised to Cdn$10.50 at Canaccord Genuity
-
Ero Copper Corp. (ERO:CN) (ERRPF) PT Raised to Cdn$20 at Canaccord Genuity
-
Capstone Mining Corp. (CS:CN) (CSFFF) PT Raised to Cdn$1 at Canaccord Genuity
-
Coeur d'Alene Mines (CDE) PT Lowered to $6 at Canaccord Genuity
-
Pan Am Silver (PAAS) PT Lowered to $20 at Canaccord Genuity
-
Cree (CREE) PT Raised to 'Street High' $81 at Canaccord Genuity
-
Nlight (LASR) PT Raised to $28 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $89 at Canaccord Genuity; 'Takeover Chatter Not Surprising'
-
Fibrocell Science (FCSC) Announces Pact with Castle Creek Pharma to Develop and Commercialize FCX-007 Gene Therapy
-
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
-
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
-
Canaccord Genuity Downgrades Imperial Metals Corp. (III:CN) (IPMLF) to Hold
-
Canaccord Genuity Downgrades First Quantum Minerals Ltd. (FM:CN) (FQVLF) to Hold
-
Director/PDMR Shareholding
-
Atalaya Mining PLC Announces First Quarter 2019 Operations Update
-
Perseus Mining Executes A$45 Million Underwriting Agreement for Warrants
-
Red Ventures Acquires HigherEducation.com
-
X4 Pharmaceuticals (XFOR) Prices 5.7M Shares at $11 w/Warrants
-
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
-
X4 Pharmaceuticals Inc. (XFOR) Announces Proposed Common Share and Class A Warrants Offering
-
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
-
Canaccord Genuity Resumes TMAC Resources (TMR:CN) (TMMFF) at Spec. Buy
-
Canaccord Genuity Downgrades PetroShale (PSH:CN) (PSHIF) to Spec. Buy
-
Troilus Announces C$12 Million Bought Deal Public Offering of Common Shares
-
NetworkNewsBreaks – Canaccord Genuity Issues ‘Speculative Buy’ Rating on Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
-
Cinedigm Digital Cinema (CIDM) PT Raised to $3 at Canaccord Genuity
-
Canaccord Genuity LLC Updates Report on Cinedigm, Reiterating Buy Rating and Increasing Price Target to $3.00
-
Canaccord Genuity LLC Updates Report on Cinedigm, Reiterating Buy Rating and Increasing Price Target to $3.00
-
Disclosure of Related Party Transaction
-
Dividend 15 Split Corp. Completes Overnight Offering of $56,489,950
-
Telaria Inc (TLRA) PT Raised to $9 at Canaccord Genuity
-
Aileron Therapeutics Inc (ALRN) PT Lowered to $5 at Canaccord Genuity
-
TransCanna meldet Abschluss seiner vermittelten Privatplatzierung von Anteilscheinen in Höhe von 16 Mio. CAD
-
Greenlane Launches Initial Public Offering
-
Sage Therapeutics (SAGE) KOL Call Takeaways - Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Totally Plc. ()
-
Canaccord Genuity Reiterates Hold Rating on Shaw Communications (SJRWF)
-
Sunniva Inc. (SNN:CN) (SNNVF) PT Lowered to Cdn$10 at Canaccord Genuity
-
MediPharm Labs Corp. (LABS:CN) (MLCPF) PT Raised to Cdn$5.50 at Canaccord Genuity
-
Aurora Cannabis Inc. (ACB:CN) (ACB) PT Raised to Cdn$13.50 at Canaccord Genuity
-
Canaccord Genuity Downgrades Southwest (LUV) to Hold

